Norris Perne & French LLP Novo Nordisk A S Transaction History
Norris Perne & French LLP
- $1.31 Billion
- Q1 2024
A detailed history of Norris Perne & French LLP transactions in Novo Nordisk A S stock. As of the latest transaction made, Norris Perne & French LLP holds 1,574 shares of NVO stock, worth $209,782. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,574Holding current value
$209,782% of portfolio
0.02%Shares
11 transactions
Others Institutions Holding NVO
# of Institutions
1,894Shares Held
310MCall Options Held
5.36MPut Options Held
4.95M-
Jennison Associates LLC21.1MShares$2.81 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.83 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.74 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.6 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.57 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $301B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...